Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03310892 · ClinicalTrials.gov registry record · NA
Tailored Messaging for CRC Screening
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 600
- Enrollment target
NCT03310892: Completed NA study, sponsored by University of Pennsylvania.
NCT03310892 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03310892, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
Study Summary
This is a randomized controlled trial to to determine whether direct, tailored messaging to patients prior to scheduling colonoscopy will increase patient adherence to provider recommendation for screening colonoscopy.
Interventions
- BEHAVIORAL Generic message
- BEHAVIORAL Tailored message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2017-10-09 |
| Est. Completion | 2023-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03310892
The ClinicalTrials.gov registry entry for NCT03310892 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Generic message is the first listed.
NCT03310892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03310892 about?
NCT03310892 is a clinical study titled "Tailored Messaging for CRC Screening". This is a randomized controlled trial to to determine whether direct, tailored messaging to patients prior to scheduling colonoscopy will increase patient adherence to provider recommendation for screening colonoscopy.
What is the current status of trial NCT03310892?
This trial is currently completed. It is a NA study. The enrollment target is 600 participants. The study started on 2017-10-09. Estimated completion is 2023-10-01.
What interventions are being tested in trial NCT03310892?
The interventions under investigation include: Generic message (BEHAVIORAL), Tailored message (BEHAVIORAL).
Who is sponsoring clinical trial NCT03310892?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.